T1	HMM 342 381	left ventricular ejection fraction (EF)
T2	HMM 386 401	cardiac volumes
T3	HMM 505 529	changes in neurohormones
T4	HMM 708 884	Temporal changes in plasma renin, angiotensin-II, aldosterone, epinephrine, norepinephrine, B-type natriuretic peptide (BNP), and N-terminal atrial natriuretic peptide (NT-ANP)
T5	HMM 1054 1125	EF, cardiac volumes, and risk for subsequent adverse clinical outcomes.
T6	HMM 1137 1140	BNP
T7	HMM 1158 1164	NT-ANP
T8	HMM 1231 1233	EF
T9	HMM 1246 1272	end-diastolic volume (EDV)
T10	HMM 1289 1308	end-systolic volume
T11	HMM 1509 1558	died or experienced heart failure hospitalization
T12	HMM 1594 1600	NT-ANP
T13	HMM 1662 1676	norepinephrine
T14	HMM 1722 1728	NT-ANP
T15	HMM 1868 1907	death or heart failure hospitalization.
T16	HMM 2020 2022	EF
T17	HMM 2027 2049	ventricular dilatation
T18	HMM 2124 2148	mortality and morbidity.
T19	HMM 2233 2255	ventricular remodeling
